Related Experiment Videos

[Expression of genes for metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis]

Genetika
|November 29, 2011
PubMed

Insights

Psoriasis is linked to increased matrix metalloproteinase (MMP) gene expression, particularly MMP-1 and MMP-12. Interleukin-17 (IL-17) may drive this upregulation in skin cells, offering insights into psoriasis pathogenesis.

Area of Science:

  • Dermatology and Molecular Biology

Context:

  • Psoriasis is a chronic inflammatory skin condition.
  • Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and inflammation.

Purpose:

  • To investigate the expression levels of specific MMP genes (MMP-1, MMP-2, MMP-9, MMP-12) in psoriatic skin lesions compared to unaffected skin.
  • To explore the role of Interleukin-17 (IL-17) in regulating MMP gene expression in keratinocytes and psoriatic skin.

Summary:

  • Real-time polymerase chain reaction (RT-PCR) revealed significantly increased mRNA levels (approximately 15-fold) for MMP-1 and MMP-12 genes in psoriatic lesions.
  • Studies on cultured human keratinocytes showed that IL-17 treatment upregulates MMP gene expression.
  • These findings suggest that IL-17 contributes to the elevated MMP gene expression observed in psoriasis-affected skin.

Impact:

  • Provides molecular insights into the pathogenesis of psoriasis.
  • Identifies potential therapeutic targets by highlighting the role of MMPs and IL-17 in psoriatic skin.
  • Contributes to understanding the inflammatory mechanisms underlying skin diseases.